查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2075304

全球足癬市場：依疾病類型、治療類型、給藥途徑、通路及地區分類。

Global Athletes Foot Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計，2026年全球足癬市場價值為14.8億美元，預計2033年將達到21.2億美元。預計從2026年到2033年，該市場將以5.2%的複合年成長率成長。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 14.8億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
2026年至2033年預測期間的複合年成長率： 5.20% 2033年市場規模預測： 21.2億美元

足癬（香港腳）是一種常見的真菌感染疾病，主要發生於足部皮膚，尤其是趾間，但也可能蔓延至趾甲和手部。之所以被稱為“香港足癬”，是因為它在運動員中較為常見。這是因為真菌在溫暖潮濕的環境中繁殖旺盛，例如運動員常穿的潮濕汗濕的鞋子。足癬的特徵是趾間和足底出現搔癢、刺痛和灼熱感。受感染的皮膚也可能發紅、脫皮、皸裂或起水皰。雖然令人不適，但通常症狀較輕，可以使用非處方藥治療。如果症狀持續時間較長或較為嚴重，則可能需要處方藥。足癬是由皮癬菌引起的，這是一種生長在皮膚死皮層上的真菌。這種真菌很容易透過直接接觸受污染的表面或透過毛巾、鞋子和衣物等間接接觸傳播。公共淋浴設備、游泳池和更衣室是真菌滋生的溫床，因此運動員和健身愛好者尤其容易感染。足部衛生對於預防足癬至關重要。這包括保持足部清潔乾燥、穿著透氣的鞋子、定期更換襪子，以及避免在可能存在足癬的公共場所赤腳行走。患有足癬的人需要注意不要將感染傳播到身體其他部位或傳染給他人。早期發現和治療足癬對於防止感染擴散或引發更嚴重的繼發性細菌感染疾病至關重要。了解足癬的原因、預防和治療方法將有助於您有效控制病情並維護足部健康。

市場動態：

全球足癬市場的主要促進因素是人口老化加劇、肥胖率上升以及游泳等水上活動參與度增加，這些因素導致感染率上升。人們對未經治療的真菌性足部感染疾病危害的健康意識不斷提高，也促進了自我診斷和非處方藥的使用。然而，使用非處方外用乳膏和粉劑等家庭療法等替代療法可能會影響處方藥的產生收入潛力。

本研究的主要特點：

  • 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球足癬市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球運動員足癬市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用各種用於分析全球運動員足癬市場的策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
      • 人們健康健康意識的提高
      • 個人護理和運動醫療保健方面的支出增加
      • 治療方法的技術進步
  • 主要亮點
  • 監管趨勢
  • 近期趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 併購和合作
  • 供給面和需求面分析
  • 經濟影響

第5章 全球足癬市場：依藥物類別分類，2021-2033年

  • 抗真菌藥物
  • 組合

第6章 全球足癬市場：依疾病適應症分類，2021-2033年

  • 腳指間
  • 腳底
  • 水痘

第7章 全球足癬市場：依給藥途徑分類，2021-2033年

  • 外用
  • 口服

第8章 全球足癬市場：依分銷管道分類，2021-2033年

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 全球足癬市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第10章 競爭格局

  • 公司簡介
    • Perrigo Company Plc.
    • Novartis AG
    • Valeant Pharmaceuticals International
    • GlaxoSmithKline plc
    • Bayer AG
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Glenmark Pharmaceutical Ltd
    • Taro Pharmaceutical Industries Ltd.
    • Camber Pharmaceuticals Inc
    • Aurobindo Pharma Ltd
  • 分析師意見

第11章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6665

Global Athlete's Foot Market is estimated to be valued at USD 1.48 Bn in 2026 and is expected to reach USD 2.12 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1.48 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.20% 2033 Value Projection: USD 2.12 Bn

Athlete's foot, also known as tinea pedis, is a common fungal infection that affects the skin on the feet, particularly the spaces between the toes, but can also spread to the toenails and hands. It is named athlete's foot because it is frequently seen in athletes, as the fungus thrives in warm, moist environments, such as the inside of sweaty shoes, which are common among sports participants. This condition is characterized by itching, stinging, and burning sensations between the toes or on the soles of the feet. The affected skin may also become red, flaky, cracked, or blistered. Although the condition can be uncomfortable, it is generally mild and can be treated with over-the-counter antifungal medications. In persistent or severe cases, prescription-strength treatments may be necessary. Athlete's foot is caused by dermatophytes, a type of fungus that grows on the dead outer layer of skin. The fungus spreads easily through direct contact with contaminated surfaces or through indirect contact with towels, shoes, or clothing. Communal showers, swimming pools, and locker rooms are hotspots for transmission, making athletes and gym-goers particularly susceptible. Good foot hygiene plays a crucial role in preventing athlete's foot. This includes keeping the feet clean and dry, wearing breathable footwear, changing socks regularly, and avoiding walking barefoot in public places where the fungus may be present. Individuals with athlete's foot should also be careful not to spread the infection to other parts of their body or to other people. Early detection and treatment of athlete's foot are important to prevent the infection from becoming more difficult to manage or leading to more serious secondary bacterial infections. Understanding the causes, prevention, and treatment options enables individuals to effectively deal with this condition and maintain good foot health.

Market Dynamics:

The global athlete's foot market is primarily driven by the rising prevalence of the infection due to a growing geriatric population, increasing obesity rates, and greater participation in aquatic activities. Growing health awareness regarding implications of untreated fungal infections of feet is also supporting self-diagnosis and over-the-counter medication. However, alternative treatment options such as home remedies using over-the-counter (OTC) topical creams and powders may hinder revenue generation potential for prescription drugs.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global athlete's foot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Perrigo Company Plc., Novartis AG, Valeant Pharmaceuticals International, GlaxoSmithKline plc, Bayer AG, Teva Pharmaceuticals Industries Ltd., Mylan NV, Glenmark Pharmaceutical Ltd, Taro Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc, Aurobindo Pharma Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global athlete's foot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global athlete's foot market

Detailed Segmentation:

  • Global Athlete's Foot Market, By Drug Class
  • Antifungals
  • Combination
  • Global Athlete's Foot Market, By Disease Indication
  • Interdigital
  • Plantar
  • Vesicular
  • Global Athlete's Foot Market, By Route of Administration
  • Topical
  • Oral
  • Global Athlete's Foot Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in Global Athlete's Foot Market:
  • Perrigo Company Plc.
  • Novartis AG
  • Valeant Pharmaceuticals International
  • GlaxoSmithKline plc
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd.
  • Mylan NV
  • Glenmark Pharmaceutical Ltd
  • Taro Pharmaceutical Industries Ltd.
  • Camber Pharmaceuticals Inc
  • Aurobindo Pharma Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Athlete€(TM)s Foot, By Drug Class
    • Market Athlete€(TM)s Foot, By Disease Indication
    • Market Athlete€(TM)s Foot, By Route of Administration
    • Market Athlete€(TM)s Foot, By Distribution Channel
    • Market Athlete€(TM)s Foot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
      • Growing health and hygiene awareness
      • Increasing spending on personal care and sports healthcare
      • Technological advancements in treatment options
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER€(TM)s Analysis
  • Mergers, Acquisitions, and Collaborations
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Athlete€(TM)s Foot Market, By Drug Class, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 €" 2033
    • Segment Trends
  • Antifungals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Combination
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Global Athlete€(TM)s Foot Market, By Disease Indication, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Interdigital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Plantar
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Vesicular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Global Athlete€(TM)s Foot Market, By Route of Administration, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022-2033
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Global Athlete€(TM)s Foot Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022-2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Global Athlete€(TM)s Foot Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2021 €"2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Company Profile
    • Perrigo Company Plc.
      • Drug Class Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Valeant Pharmaceuticals International
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceuticals Industries Ltd.
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mylan NV
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Glenmark Pharmaceutical Ltd
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Taro Pharmaceutical Industries Ltd.
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Camber Pharmaceuticals Inc
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Aurobindo Pharma Ltd
      • Company Highlights
      • Drug Class Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us